| __timestamp | Jazz Pharmaceuticals plc | Veracyte, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 406114000 | 40786000 |
| Thursday, January 1, 2015 | 449119000 | 47876000 |
| Friday, January 1, 2016 | 502892000 | 52035000 |
| Sunday, January 1, 2017 | 544156000 | 55348000 |
| Monday, January 1, 2018 | 683530000 | 65276000 |
| Tuesday, January 1, 2019 | 736942000 | 82720000 |
| Wednesday, January 1, 2020 | 854233000 | 89118000 |
| Friday, January 1, 2021 | 1451683000 | 181193000 |
| Saturday, January 1, 2022 | 1416967000 | 174078000 |
| Sunday, January 1, 2023 | 1343105000 | 184232000 |
Unleashing insights
In the ever-evolving pharmaceutical landscape, understanding spending patterns is crucial. Jazz Pharmaceuticals and Veracyte, Inc. have shown distinct trajectories in their Selling, General, and Administrative (SG&A) expenses over the past decade. From 2014 to 2023, Jazz Pharmaceuticals' SG&A expenses surged by approximately 230%, peaking in 2021. This growth reflects their aggressive expansion and strategic investments. In contrast, Veracyte, Inc. exhibited a more moderate increase of around 350% during the same period, indicating a steady scaling of operations.
By 2023, Jazz Pharmaceuticals' SG&A expenses were nearly seven times higher than Veracyte's, highlighting their larger operational scale. However, Veracyte's consistent growth underscores its potential in the biotech sector. These spending patterns not only reveal each company's strategic priorities but also provide insights into their market positioning and future growth prospects.
Who Optimizes SG&A Costs Better? Alnylam Pharmaceuticals, Inc. or Jazz Pharmaceuticals plc
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
BioMarin Pharmaceutical Inc. and Jazz Pharmaceuticals plc: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Jazz Pharmaceuticals plc vs Alpine Immune Sciences, Inc.
Operational Costs Compared: SG&A Analysis of Alpine Immune Sciences, Inc. and Veracyte, Inc.
PTC Therapeutics, Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?
Veracyte, Inc. and Catalyst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Veracyte, Inc. and ImmunityBio, Inc.
SG&A Efficiency Analysis: Comparing Veracyte, Inc. and Arrowhead Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Veracyte, Inc. and Geron Corporation
Comparing SG&A Expenses: Veracyte, Inc. vs Taro Pharmaceutical Industries Ltd. Trends and Insights
Breaking Down SG&A Expenses: Veracyte, Inc. vs Viridian Therapeutics, Inc.